Treatment of Bromhidrosis with a 2% Glycopyrrolate Spray: A Retrospective Cohort Study
Clinical & Experimental Dermatology and Therapies · 2022
DOI: 10.29011/2575-8268.100192 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Clinical & Experimental Dermatology and Therapies, 2022.
Abstract (Originalsprache)
Background
Body odour, or bromhidrosis, is common and causes psychological distress.Current treatment options are limited in efficacy and severe side effects are not uncommon.Therefore, we formulated a topical spray containing glycopyrrolate 2%w/v to inhibit axillary apocrine and eccrine secretions, together with isopropyl alcohol and caprylyl glycol to reduce skin bacterial colonisation.
Objective
To review the efficacy and safety of 2% glycopyrrolate spray in the treatment of bromhidrosis in patients who failed treatment with topical aluminium salts.
Methods
In this retrospective cohort study, 18 patients aged 16-52 years old were included.The glycopyrrolate spray was applied to the axillae once to twice daily for 3 months and changes in a 5-point subjective bromhidrosis scale and the 4-point Hyperhidrosis Disease Severity Scale (HDSS) were evaluated.
Results
The mean bromhidrosis score significantly improved from 2.72 (±0.83) pre-treatment to 0.47 (±0.61) post-treatment (p
Zitieren
APA
(2022). Treatment of Bromhidrosis with a 2% Glycopyrrolate Spray: A Retrospective Cohort Study. Clinical & Experimental Dermatology and Therapies. https://doi.org/10.29011/2575-8268.100192
Vancouver
Treatment of Bromhidrosis with a 2% Glycopyrrolate Spray: A Retrospective Cohort Study. Clinical & Experimental Dermatology and Therapies. 2022. doi:10.29011/2575-8268.100192
BibTeX
@article{euvimed2022,
title = {Treatment of Bromhidrosis with a 2% Glycopyrrolate Spray: A Retrospective Cohort Study},
journal = {Clinical & Experimental Dermatology and Therapies},
year = {2022},
doi = {10.29011/2575-8268.100192}
}
EUVIMED